The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 178, 6038 -6042
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walter, L.
Right arrow Articles by Albert, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walter, L.
Right arrow Articles by Albert, M. L.

Cutting Edge: Cross-Presented Intracranial Antigen Primes CD8+ T Cells1

Lisa Walter* and Matthew L. Albert2,*,{dagger}

* Department of Immunology, Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris France; and {dagger} Institut Nationale de la Santé et de la Recherche Médicale Unité 818, Paris, France

The CNS is considered immune privileged due to the blood-brain barrier and the absence of conventional lymphatics. Nonetheless, T cell immune responses specific for CNS Ag have been documented. Where these events are initiated and what cellular mechanisms are involved remain unknown. In this study, we established an experimental mouse model to evaluate the requirements for priming CD8+ T cells following the cross-presentation of intracranial Ag. Surprisingly, we find that even with a damaged blood-brain barrier, Ag presentation occurs in regional lymph nodes and not within the CNS itself. Only once the responding cells have expanded can they traffic to the site of CNS injury. Cross-presentation of intracranial Ag is efficient and the subsequent priming of CD8+ T cells is dependent on CD4+ T cell help and CD40 signaling in host APCs. Our findings have important implications for the initiation of T cell immune responses toward CNS Ags.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by The European Young Investigator Award Scheme, European Science Foundation (to M.L.A.) and the European Molecular Biology Organization Long-Term Fellowship (to L.W.).

2 Address correspondence and reprint requests to Dr. Matthew L. Albert, Department of Immunology, Institut Pasteur, 25, Rue du Dr. Roux, Paris, France 75724. E-mail address: albertm{at}pasteur.fr

3 Abbreviations used in this paper: IC, intracranial(ly); DC, dendritic cell; LN, lymph node; WT, wild type; IF, intrafootpad.




This article has been cited by other articles:


Home page
FASEB J.Home page
N. Melzer, S. G. Meuth, and H. Wiendl
CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability
FASEB J, November 1, 2009; 23(11): 3659 - 3673.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. R. F. Smith, X. Tang, I. Maricic, Z. Garcia, S. Fanchiang, and V. Kumar
Dendritic Cells Use Endocytic Pathway for Cross-Priming Class Ib MHC-Restricted CD8{alpha}{alpha}+TCR{alpha}{beta}+ T Cells with Regulatory Properties
J. Immunol., June 1, 2009; 182(11): 6959 - 6968.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.